tiprankstipranks
Advertisement
Advertisement

Realbotix Spins Off Commercial Robotics Arm in All-Stock NASDAQ Deal With Onconetix

Story Highlights
  • Realbotix is selling its commercial robotics subsidiary to Onconetix in an all-stock deal, gaining a controlling equity and board stake.
  • The transaction separates Realbotix’s B2B robotics from its adult consumer business while elevating the commercial unit onto NASDAQ.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Meet Samuel – Your Personal Investing Prophet

Tokens.com Corp ( (TSE:XBOT) ) has shared an update.

Realbotix Corp. has agreed to sell 100% of its Nevada-based subsidiary Realbotix, LLC to NASDAQ-listed Onconetix, Inc. in an all-stock deal, transferring its robotics engineering teams, AI software developers and key patents. Realbotix will receive between 75% and 90% of Onconetix’s post-closing fully diluted common stock, depending on Onconetix’s net cash at closing, and will control four of five board seats.

Following completion, Realbotix, LLC will become a wholly owned subsidiary of Onconetix, which will remain listed on NASDAQ and rebrand under the Realbotix name or a similar variant. The structure effectively separates Realbotix’s commercial robotics arm from its adult consumer-focused Abyss Creations business, while giving the commercial unit a U.S. senior exchange platform and preserving Realbotix’s controlling economic and governance stake.

The move positions the commercial humanoid robotics business as a dedicated, U.S.-listed AI and robotics player, potentially enhancing visibility with institutional investors and clarifying the parent company’s portfolio for shareholders. Realbotix also granted 150,000 stock options to newly appointed chief financial officer Scott Meyers, reinforcing its leadership team as it navigates the transaction and continued development of its remaining consumer-focused operations.

The most recent analyst rating on (TSE:XBOT) stock is a Buy with a C$0.70 price target. To see the full list of analyst forecasts on Tokens.com Corp stock, see the TSE:XBOT Stock Forecast page.

More about Tokens.com Corp

Realbotix Corp. is a Nevada-based developer of AI-powered humanoid robots, operating through two main subsidiaries with distinct markets. Realbotix, LLC focuses on B2B commercial deployments in customer service, healthcare, education, hospitality and entertainment, while Abyss Creations targets adult consumers with silicone-based companionship and wellness products sold directly.

Average Trading Volume: 267,482

Technical Sentiment Signal: Sell

Current Market Cap: C$73.33M

For an in-depth examination of XBOT stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1